Antibiotic Strategy and Asymptomatic Bacteriuria in the Context of Intra-vesical Botulinum Toxin A Injections.

Exclusion Criteria

• •Having already participated to the study
• •Augmentation cystoplasty
• •Bladder compliance disorders (\<20 mL/cmH2O)
• •Ongoing cyclic antibiotic therapy
• •Ongoing corticosteroid therapy
• •Modification of immunosuppressive or immunomodulatory therapy in the 3 months before inclusion (MS patients)
• •Antibiotic therapy in the month before inclusion
• •Surgical procedure in the 3 months before and the 6 weeks following inclusion
• •Symptomatic UTI at the time of inclusion
• •Associated neurologic disease
• •Pregnancy or breast feeding
• •Individuals especially in need of protection
• •No informed consent
• •Patients incapable to follow the trial, e.g. because of language problems, psychiatric disorders, dementia and so on
• •Immunocompromised patients